Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: LivaNova PLC

Market Cap 4.31B 3.77B 3.49B 3.25B 6.11B 408B 6.15B 41.42B 16.12B 200B 16.19B 15.84B 696B P/E 2026 *
28.3x
P/E 2027 * 24.4x
Enterprise Value 4.33B 3.79B 3.5B 3.27B 6.14B 409B 6.18B 41.61B 16.19B 201B 16.27B 15.91B 699B EV / Sales 2026 *
2.87x
EV / Sales 2027 * 2.57x
Free-Float
98.5%
Yield 2026 *
-
Yield 2027 * -
1 day+1.27%
1 week+0.13%
Current month+8.13%
1 month+8.09%
3 months+26.19%
6 months+26.57%
Current year+29.69%
1 week 77.71
Extreme 77.71
80.94
1 month 70.74
Extreme 70.7401
80.96
Current year 56.44
Extreme 56.44
80.96
1 year 41.02
Extreme 41.015
80.96
3 years 32.48
Extreme 32.48
80.96
5 years 32.48
Extreme 32.48
93.89
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 2024-02-29
Director of Finance/CFO 56 2020-10-30
Investor Relations Contact - 2022-07-31
Director TitleAgeSince
Director/Board Member 68 2015-10-18
Director/Board Member 58 2015-10-18
Chairman 74 2021-06-08
Date Insider Type Main position Quantity % Market Cap.
06-14Fiscal year

Director

10,953 0.0199%
06-14Fiscal year

Director

10,953 0.0199%
06-14Fiscal year

Director

10,953 0.0199%
Change 5-day change 1-year change 3-year change Capi.($)
+1.15%+0.13%+75.12%+58.59% 4.31B
-0.11%-0.33%-33.68%-18.36% 154B
+0.09%-1.16%-7.57%-9.11% 102B
-0.99%+2.10%+59.76%+56.65% 56.51B
+0.09%-3.27%-7.13%+44.91% 52.89B
-1.52%-2.31%-16.24%-44.91% 39.67B
-1.60%-5.14% - - 30.39B
-4.81%-6.63%-13.20%-45.23% 27.96B
-0.09%-1.08%+51.29%-11.07% 23.17B
+0.90%+2.05%-14.45%-4.79% 20.35B
Average -0.69%-1.35%+10.43%+2.96% 51.08B
Weighted average by Cap. -0.59%-1.24%-5.72%-2.75%

Financials

2026 *2027 *
Net sales 1.51B 1.32B 1.22B 1.14B 2.14B 143B 2.15B 14.49B 5.64B 70.07B 5.66B 5.54B 243B 1.61B 1.41B 1.3B 1.22B 2.29B 153B 2.3B 15.5B 6.03B 74.99B 6.06B 5.93B 261B
Net income 146M 128M 118M 110M 207M 13.82B 209M 1.4B 547M 6.8B 549M 537M 23.61B 179M 156M 145M 135M 253M 16.91B 255M 1.72B 669M 8.31B 672M 657M 28.88B
Net Debt 20.06M 17.53M 16.21M 15.13M 28.41M 1.9B 28.61M 193M 74.96M 932M 75.31M 73.68M 3.24B -167M -146M -135M -126M -237M -15.79B -238M -1.6B -624M -7.76B -627M -614M -26.97B
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
26-06-22 79.80 $ +1.66% 170,115
26-06-18 78.50 $ 0.00% 1,427,477
26-06-17 78.50 $ -1.23% 626,527
26-06-16 79.48 $ -0.28% 911,924
26-06-15 79.70 $ +0.39% 755,855
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
78.50USD
Average target price
81.50USD
Spread / Average Target
+3.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LIVN Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!